We are live on ! Find out more
ESRX

Express Scripts Holding Company
ESRX

Delisted

ESRX was delisted on the 20th of December, 2018.

1,253 hedge funds and large institutions have $58B invested in Express Scripts Holding Company in 2015 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 455 increasing their positions, 473 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more call options, than puts

Call options by funds: $962M | Put options by funds: $449M

66% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 58

6% more capital invested

Capital invested by funds: $54.9B → $58B (+$3.18B)

4% more funds holding in top 10

Funds holding in top 10: 102106 (+4)

2% more funds holding

Funds holding: 1,2261,253 (+27)

4% less repeat investments, than reductions

Existing positions increased: 455 | Existing positions reduced: 473

Holders
1,253
Holders Change
+27
Holders Change %
+2.2%
% of All Funds
33.76%
Holding in Top 10
106
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+3.92%
% of All Funds
2.86%
New
96
Increased
455
Reduced
473
Closed
58
Calls
$962M
Puts
$449M
Net Calls
+$513M
Net Calls Change
+$425M
Name Holding Trade Value Shares
Change
Change in
Stake
FNBOO
1251
First National Bank of Omaha
Nebraska
$1.51K
FHC
1252
First Heartland Consultants
Missouri
$1.23K +$25.5K +292 +2%
LFR
1253
Lehman Financial Resources
Pennsylvania
$1K
1GA
1254
1st Global Advisors
Texas
$859 +$428K +4,895 +103%
UB
1255
UMB Bank
Missouri
$388 +$40.8K +467 +12%
TP
1256
Tesuji Partners
New Jersey
-$156M -1,800,000 Closed
GE
1257
General Electric
Ohio
-$128M -1,480,850 Closed
CI
1258
Cambiar Investors
Colorado
-$78.8M -908,525 Closed
Renaissance Technologies
1259
Renaissance Technologies
New York
-$78.8M -908,139 Closed
HCM
1260
Highbridge Capital Management
New York
-$58.1M -669,957 Closed
VanEck Associates
1261
VanEck Associates
New York
-$47.8M -551,441 Closed
SM
1262
Seminole Management
New York
-$46.6M -537,210 Closed
NTC
1263
North Tide Capital
Massachusetts
-$43.4M -500,000 Closed
FCM
1264
Farallon Capital Management
California
-$19.4M -223,000 Closed
SCM
1265
Symons Capital Management
Pennsylvania
-$12.8M -147,725 Closed
Jacobs Levy Equity Management
1266
Jacobs Levy Equity Management
New Jersey
-$10.4M -120,000 Closed
BJCM
1267
Blue Jay Capital Management
California
-$9.76M -112,500 Closed
IG
1268
ING Group
Netherlands
-$6.43M -74,068 Closed
HHC
1269
Hutchin Hill Capital
New York
-$6.06M -69,800 Closed
QI
1270
Quotient Investors
New York
-$5.01M -57,749 Closed
FAAM
1271
First Allied Asset Management
California
-$3.79M -42,850 Closed
CIM
1272
Calvert Investment Management
Maryland
-$2.82M -32,464 Closed
WIM
1273
Waverton Investment Management
United Kingdom
-$2.77M -31,970 Closed
FBB
1274
Fulton Breakefield Broenniman
Maryland
-$2.67M -30,713 Closed
MF
1275
Magnetar Financial
Illinois
-$2.22M -25,597 Closed

ESRX Hedge Fund Activity: Q2 2015 in Review

1,253 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Express Scripts Holding Company (ESRX) for Q2 2015, worth a combined $58B — up 5.8% from $54.9B a quarter earlier.

Buyers outnumbered sellers: 96 funds opened new ESRX positions and 58 closed out — a net gain of 38 holders — while 455 added to existing stakes and 473 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.7B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $909M.

  • 1,253 institutional investors held Express Scripts Holding Company (ESRX) as of Q2 2015, up from 1,226 in Q1 2015.
  • Funds reported $58B of Express Scripts Holding Company stock for Q2 2015, up 5.8% quarter-over-quarter.
  • 96 funds opened new Express Scripts Holding Company positions in Q2 2015 and 58 closed out, a net change of +38 holders.
  • The largest Express Scripts Holding Company buyer in Q2 2015 was Morgan Stanley, an estimated $2.7B added.
  • The largest Express Scripts Holding Company seller in Q2 2015 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $909M sold.

Based on aggregated 13F filings for Q2 2015.